Breast cancer is the most common cancer in women worldwide. 1 in 8 women will be diagnosed with breast cancer in their lifetime. More than 250,000 new diagnosed cases of breast cancer are expected annually.
It's Breast Cancer Awareness Month, and we salute women everywhere who are undergoing or have undergone treatment for breast cancer. It requires a level of bravery that many of us cannot imagine. We're inspired by the strength and courage which you display, and we hope you will free to talk with us.
The National Institute of Health is subject to the same roadblocks as all of us, regarding research into cannabinoids, so there is not necessarily a huge wealth of research regarding CBD and Breast Cancer. There have been a few promising trials:
- Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
- Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy
- Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
- Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells
- Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration